Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques

Virology

Volumn 318, Issue 1, 2004, Pages 267-279

  Balfe, Peter ^a,b   Shapiro, Sarah ^a   Hsu, Mayla ^a   Buckner, Clarisa ^a   Harouse, Janet M ^a   Cheng Mayer, Cecilia ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adaptive evolution; Quasispecies diversity; Seronegative macaques

Indexed keywords

GLYCOPROTEIN GP 120;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MACACA; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIVERSITY; VIREMIA; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1242342134     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.09.022     Document Type: Article

References (54)

1. Bogers W.M., Cheng-Mayer C., Montelaro R.C. Developments in preclinical AIDS vaccine efficacy models. Aids. 14(Suppl. 3):2000;S141-S151.
2. Cayabyab M., Karlsson G.B., Etemad-Moghadam B.A., Hofmann W., Steenbeke T., Halloran M., Fanton J.W., Axthelm M.K., Letvin N.L., Sodroski J.G. Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). J. Virol. 73(2):1999;976-984.
3. Chakrabarti L.A., Ivanovic T., Cheng-Mayer C. Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones. J. Virol. 76(4):2002;1588-1599.
4. Cheng-Mayer C., Brown A., Harouse J., Luciw P.A., Mayer A.J. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73(7):1999;5294-5300.
5. Clements J.E., Montelaro R.C., Zink M.C., Amedee A.M., Miller S., Trichel A.M., Jagerski B., Hauer D., Martin L.N., Bohm R.P.et al. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69(5):1995;2737-2744.
6. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206(2):1995;935-944.
7. Delwart E.L., Gordon C.J. Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis. Methods. 12(4):1997;348-354.
8. Endo Y., Igarashi T., Nishimura Y., Buckler C., Buckler-White A., Plishka R., Dimitrov D.S., Martin M.A. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus. J. Virol. 74(15):2000;6935-6945.
9. Etemad-Moghadam B., Sun Y., Nicholson E.K., Karlsson G.B., Schenten D., Sodroski J. Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo. J. Virol. 73(10):1999;8873-8879.
10. Etemad-Moghadam B., Sun Y., Nicholson E.K., Fernandes M., Liou K., Gomila R., Lee J., Sodroski J. Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo. J. Virol. 74(9):2000;4433-4440.
11. Fox D.G., Balfe P., Palmer C.P., May J.C., Arnold C., McKeating J.A. Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site. J. Virol. 71(1):1997;759-765.
12. Gao F., Yue L., White A.T., Pappas P.G., Barchue J., Hanson A.P., Greene B.M., Sharp P.M., Shaw G.M., Hahn B.H. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature. 358(6386):1992;495-499.
13. Greenier J.L., Miller C.J., Lu D., Dailey P.J., Lu F.X., Kunstman K.J., Wolinsky S.M., Marthas M.L. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J. Virol. 75(8):2001;3753-3765.
14. Hammond A.L., Lewis J., May J., Albert J., Balfe P., McKeating J.A. Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization. J. Virol. 75(12):2001;5593-5603.
15. Harouse J.M., Gettie A., Tan R.C., Blanchard J., Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science. 284(5415):1999;816-819.
16. Harouse J.M., Gettie A., Eshetu T., Tan R.C., Bohm R., Blanchard J., Baskin G., Cheng-Mayer C. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J. Virol. 75(4):2001;1990-1995.
17. Hayami M., Igarashi T. SIV/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine. Leukemia. 11(Suppl. 3):1997;95-97.
18. Hayman A., Moss T., Simmons G., Arnold C., Holmes E.C., Naylor-Adamson L., Hawkswell J., Allen K., Radford J., Nguyen-Van-Tam J., Balfe P. Phylogenetic analysis of multiple heterosexual transmission events involving subtype B of HIV type 1. AIDS Res. Hum. Retroviruses. 17(8):2001;689-695.
19. Hofmann-Lehmann R., Vlasak J., Chenine A.L., Li P.L., Baba T.W., Montefiori D.C., McClure H.M., Anderson D.C., Ruprecht R.M. Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage. J. Virol. 76(10):2002;5278-5284.
20. Hsu M., Harouse J.M., Gettie A., Buckner C., Blanchard J., Cheng-Mayer C. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. J. Virol. 77(2):2003;989-998.
21. Joag S.V., Li Z., Foresman L., Stephens E.B., Zhao L.J., Adany I., Pinson D.M., McClure H.M., Narayan O. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 70(5):1996;3189-3197.
22. Joag S.V., Li Z., Foresman L., Pinson D.M., Raghavan R., Zhuge W., Adany I., Wang C., Jia F., Sheffer D., Ranchalis J., Watson A., Narayan O. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res. Hum. Retroviruses. 13(8):1997;635-645.
23. Karlsson A.C., Lindback S., Gaines H., Sonnerborg A. Characterization of the viral population during primary HIV-1 infection. Aids. 12(8):1998;839-847.
24. Karlsson G.B., Halloran M., Schenten D., Lee J., Racz P., Tenner-Racz K., Manola J., Gelman R., Etemad-Moghadam B., Desjardins E., Wyatt R., Gerard N.P., Marcon L., Margolin D., Fanton J., Axthelm M.K., Letvin N.L., Sodroski J. The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J. Exp. Med. 188(6):1998;1159-1171.
25. Kimata J.T., Kuller L., Anderson D.B., Dailey P., Overbaugh J. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5(5):1999;535-541.
26. Kline R.L., McNairn D., Holodniy M., Mole L., Margolis D., Blattner W., Quinn T.C. Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay. J. Clin. Microbiol. 34(11):1996;2650-2653.
27. Lewis J., Balfe P., Arnold C., Kaye S., Tedder R.S., McKeating J.A. Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants. J. Virol. 72(11):1998;8943-8951.
28. Liu S.L., Schacker T., Musey L., Shriner D., McElrath M.J., Corey L., Mullins J.I. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71(6):1997;4284-4295.
29. Luciw P.A., Mandell C.P., Himathongkham S., Li J., Low T.A., Schmidt K.A., Shaw K.E., Cheng-Mayer C. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques. Virology. 263(1):1999;112-127.
30. Lue J., Hsu M., Yang D., Marx P., Chen Z., Cheng-Mayer C. Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1. J. Virol. 76(20):2002;10299-10306.
31. Lukashov V.V., Kuiken C.L., Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69(11):1995;6911-6916.
32. McKeating J.A., Zhang Y.J., Arnold C., Frederiksson R., Fenyo E.M., Balfe P. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera. Virology. 220(2):1996;450-460.
33. Moore C.B., John M., James I.R., Christiansen F.T., Witt C.S., Mallal S.A. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science. 296(5572):2002;1439-1443.
34. Nei M., Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3(5):1986;418-426.
35. Nowak M.A., Anderson R.M., McLean A.R., Wolfs T.F., Goudsmit J., May R.M. Antigenic diversity thresholds and the development of AIDS. Science. 254(5034):1991;963-969.
36. Overbaugh J., Bangham C.R. Selection forces and constraints on retroviral sequence variation. Science. 292(5519):2001;1106-1109.
37. Overbaugh J., Luciw P.A., Hoover E.A. Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections. Aids. 11(Suppl. A):1997;S47-54.
38. Palmer C., Balfe P., Fox D., May J.C., Frederiksson R., Fenyo E.M., McKeating J.A. Functional characterization of the V1V2 region of human immunodeficiency virus type 1. Virology. 220(2):1996;436-449.
39. Reimann K.A., Tenner-Racz K., Racz P., Montefiori D.C., Yasutomi Y., Lin W., Ransil B.J., Letvin N.L. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68(4):1994;2362-2370.
40. Reimann K.A., Li J.T., Veazey R., Halloran M., Park I.W., Karlsson G.B., Sodroski J., Letvin N.L. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70(10):1996;6922-6928.
41. Richman D.D., Wrin T., Little S.J., Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 100(7):2003;4144-4149.
42. Rogers J.S., Swofford D.L. A fast method for approximating maximum likelihoods of phylogenetic trees from nucleotide sequences. Syst. Biol. 47(1):1998;77-89.
43. Ross H.A., Rodrigo A.G. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J. Virol. 76(22):2002;11715-11720.
44. Shankarappa R., Gupta P., Learn G.H. Jr., Rodrigo A.G., Rinaldo C.R. Jr., Gorry M.C., Mullins J.I., Nara P.L., Ehrlich G.D. Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology. 241(2):1998;251-259.
45. Shpaer E.G., Mullins J.I. Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses. J. Mol. Evol. 37(1):1993;57-65.
46. Si Z., Cayabyab M., Sodroski J. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys. J. Virol. 75(9):2001;4208-4218.
47. Tan R.C., Harouse J.M., Gettie A., Cheng-Mayer C. In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein. J. Med. Primatol. 28(4-5):1999;164-168.
48. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22(22):1994;4673-4680.
49. Thorstensson R., Walther L., Putkonen P., Albert J., Biberfeld G. A capture enzyme immunoassay for detection of HIV-2/SIV antigen. J. Acquired Immune Defic. Syndr. 4(4):1991;374-379.
50. Valli P.J., Goudsmit J. Structured-tree topology and adaptive evolution of the simian immunodeficiency virus SIVsm envelope during serial passage in rhesus macaques according to likelihood mapping and quartet puzzling. J. Virol. 72(5):1998;3673-3683.
51. Valli P.J., Lukashov V.V., Heeney J.L., Goudsmit J. Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage. J. Virol. 72(9):1998;7494-7500.
52. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. Antibody neutralization and escape by HIV-1. Nature. 422(6929):2003;307-312.
53. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science. 280(5371):1998;1884-1888.
54. Yang Z., Nielsen R. Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Mol. Biol. Evol. 17(1):2000;32-43.